Literature DB >> 16798482

Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients.

Chinnusamy Palanivelu1, Anand Prakash, Rangaswamy Senthilkumar, Palanisamy Senthilnathan, Ramakrishnan Parthasarathi, Pidigu Seshiyer Rajan, S Venkatachlam.   

Abstract

BACKGROUND: To evaluate outcomes after minimally invasive or thoracolaparoscopic esophagectomy (TLE) with thoracoscopic mobilization of the esophagus and mediastinal esophagectomy in prone position. Esophagectomies are being performed increasingly by a minimally invasive route with decreased morbidity and shorter hospital stay compared with conventional esophagectomy. Most series report thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in the left lateral position with respiratory complications up to 8% and prolonged operative time, probably because of inadequate stance of the surgeon during the thoracoscopic part. This study shows the potential of the thoracoscopic part of the procedure in prone position to ease these difficulties. STUDY
DESIGN: From January 1997 through April 2005, TLE was performed in 130 patients. All patients had histologically proved squamous cell carcinoma of the middle third of the esophagus. Only one (0.77%) patient received neoadjuvant chemotherapy. The thoracoscopic part of the procedure was performed in prone position with excellent ergonomics, translating into less operative time and better respiratory results. We performed a minilaparotomy to retrieve the specimen owing to bulky tumors. Feeding jejunostomy and pyloromyotomy were performed in all patients.
RESULTS: There were 102 men and 28 women. Median age was 67.5 years (range 38 to 78 years). There was no conversion to open method. Median ICU stay was 1 day (range 1 to 32 days) and median hospital stay was 8 days (range 4 to 68 days). Perioperative mortality was 1.54% (n = 2). Anastomotic leak rate was 2.31% (n = 3). There was no incidence of tracheal or lung injury and a very low incidence of postoperative pneumonia. At mean followup of 20 months (range 2 to 70 months), stage-specific survival was similar to open and other minimally invasive series.
CONCLUSIONS: TLE with thoracoscopic part in prone position is technically feasible, with a low incidence of respiratory complications and less operative time required. It provides comparable outcomes with other techniques of minimally invasive esophagectomy and most open series. In our experience, we observed a low mortality rate (1.54%), hospital stay of 8 days, and low incidence of postoperative pneumonia. It has the potential to replace conventional and other techniques of minimally invasive esophagectomy.

Entities:  

Mesh:

Year:  2006        PMID: 16798482     DOI: 10.1016/j.jamcollsurg.2006.03.016

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  154 in total

1.  Outcomes after minimally invasive esophagectomy: review of over 1000 patients.

Authors:  James D Luketich; Arjun Pennathur; Omar Awais; Ryan M Levy; Samuel Keeley; Manisha Shende; Neil A Christie; Benny Weksler; Rodney J Landreneau; Ghulam Abbas; Matthew J Schuchert; Katie S Nason
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

2.  A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma.

Authors:  Hiroyuki Daiko; Mitsuyo Nishimura
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

Review 3.  Thoracoscopic esophagectomy in the prone position.

Authors:  Omar A Jarral; Sanjay Purkayastha; Thanos Athanasiou; Ara Darzi; George B Hanna; Emmanouil Zacharakis
Journal:  Surg Endosc       Date:  2012-03-07       Impact factor: 4.584

Review 4.  Minimally invasive esophagectomy.

Authors:  Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

5.  Uniportal video-assisted thoracic surgery lobectomy in semiprone position: primary experience of 105 cases.

Authors:  Zongwu Lin; Junjie Xi; Songtao Xu; Wei Jiang; Lin Wang; Qun Wang
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 6.  Laparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directions.

Authors:  Juan C Rodríguez-Sanjuán; Marcos Gómez-Ruiz; Soledad Trugeda-Carrera; Carlos Manuel-Palazuelos; Antonio López-Useros; Manuel Gómez-Fleitas
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

7.  Usefulness of robot-assisted thoracoscopic esophagectomy.

Authors:  Yoshiaki Osaka; Shingo Tachibana; Yoshihiro Ota; Takeshi Suda; Yosuke Makuuti; Takafumi Watanabe; Kenichi Iwasaki; Kenji Katsumata; Akihiko Tsuchida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-02-03

8.  Video-assisted thoracoscopic lobectomy with the patient in the semi-prone position: initial experience and benefits of lymph node dissection.

Authors:  Takuro Miyazaki; Takeshi Nagayasu; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Tsutomu Tagawa; Masayuki Obatake; Atsushi Nanashima; Shigekazu Hidaka; Tomayoshi Hayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-28

9.  Comparison of short-term outcomes between prone and lateral decubitus positions for thoracoscopic esophagectomy.

Authors:  Jin Teshima; Go Miyata; Takashi Kamei; Toru Nakano; Shigeo Abe; Kazunori Katsura; Yusuke Taniyama; Tadashi Sakurai; Makoto Hikage; Takanobu Nakamura; Kai Takaya; Masashi Zuguchi; Hiroshi Okamoto; Ozawa Youhei; Noriaki Ohuchi
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

10.  Has there been a paradigm shift in mediastinal surgery from open to minimally invasive, and from magnetic resonance imaging (MRI) to positron emission tomography-computerized tomography (PET-CT) in the last decade?

Authors:  Alper Toker; Suat Erus; Erkan Kaba; Serhan Tanju; Berker Ozkan
Journal:  Surg Endosc       Date:  2013-10-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.